Uptake of pneumococcal vaccines in older Australian adults before and after universal public funding of PCV13

CONCLUSIONS: Changes in uptake of PCV13 and PPV23 among those aged 70 + years were consistent with program changes. However, PCV13 uptake was still substantially lower in individuals aged 65-69 years overall and in those with comorbidities.PMID:38584056 | DOI:10.1016/j.vaccine.2024.04.012

Source: Vaccine - April 7, 2024 Category: Allergy & Immunology Authors: Fariha Binte Hossain David Muscatello Sanjay Jayasinghe Jitendra Jonnagaddala Bette Liu Source Type: research